Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -1,929 | N/A | N/A |
| Depreciation Amortization | 45 | N/A | N/A |
| Other Working Capital | 147 | N/A | N/A |
| Other Operating Activity | 80 | 0 | 0 |
| Operating Cash Flow | $-1,658 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -50 | N/A | N/A |
| PPE Investments | -754 | N/A | N/A |
| Investing Cash Flow | $-804 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 10,004 | N/A | N/A |
| Other Financing Activity | -1,137 | 0 | 0 |
| Financing Cash Flow | $8,867 | $N/A | $N/A |
| End Cash Position | 6,405 | N/A | N/A |
| Net Cash Flow | $6,405 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,658 | N/A | N/A |
| Capital Expenditure | -754 | N/A | N/A |
| Free Cash Flow | -2,412 | 0 | 0 |